Although serum level of TNF-α was higher in responders, this alteration did not reach statistical significance ( Figure 1 D).
← all excerpts
IL-33 as a Marker of Poor Early Response in Neuroendocrine Tumor Patients Undergoing Peptide Receptor Radionuclide Therapy.
1
—
—